Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study
Sotirios Tsimikas, Nicholas J. Viney, Steven G. Hughes, Walter Singleton, Mark J. Graham, Brenda F. Baker, Jennifer Burkey, Qingqing Yang, Santica M. Marcovina, Richard S. Geary, Rosanne M. Crooke, Joseph Lee Witztum
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1016/s0140-6736(15)61252-1
- Published
- Jul 22, 2015
- Venue
- The Lancet
- DOI
- 10.1016/s0140-6736(15)61252-1
- PubMed
- 26210642
- Categories
- Lipoproteins and Cardiovascular Health
- Provenance
- openalex